Search Result "H-Ras P21"


Computer-Aided Drug Design for Cancer-Causing H-Ras p21 Mutant Protein

Journal: Letters in Drug Design & Discovery
Volume: 6 Issue: 1 Year: 2009 Page: 14-20
Author(s): Mannu Jayakanthan, Gulshan Wadhwa, Thangavel Madhan Mohan, Loganathan Arul, Ponnusamy Balasubramanian, Durai Sundar

Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 110-124
Author(s): Yu-Wen E. Chang, Ronald R. Bean, Rolf Jakobi

Review Article

The Interplay between Noncoding RNAs and p21 Signaling in GastrointestinalCancer: From Tumorigenesis to MetastasisFarzad Rahmani1,2,3,*, Mehrdad Zandigohar4, Pegah Safavi5

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 10 Year: 2023 Page: 766-776
Author(s): Seyed Mahdi Hassanian

Anti-cancer Peptides from Ras-P21 and P53 Proteins

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2677-2698
Author(s): Matthew R. Pincus, Maly Fenelus, Ehsan Sarafraz-Yazdi, Victor Adler, Wilbur Bowne, Josef Michl

General Research Article

Design Graph Theoretical Analysis and In Silico Modeling of Dunaliella Bardawil Biomass Encapsulated N-Succinyl Chitosan Nanoparticles for Enhanced Anticancer Activity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 1900-1918
Author(s): Pavadai Parasuraman,Theivendren Panneerselvam,Selvaraj Kunjiappan,Balasubramanian Somasundaram,Shrinivas D. Joshi,Indhumathy Murugan,Murugesan Sankaranarayanan,Sankarganesh Arunachalam

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 168-175
Author(s): G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero, A. Nencioni

Research Article

Perspectives on the Role of P21-Activated Kinase 1 (PAK1) in the IntestinalAnti-inflammatory and Antitumor Potential of Artepillin C

Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-5
Author(s): Luisa Mota da Silva

The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 2 Year: 2012 Page: 85-96
Author(s): L. A. Stivala, O. Cazzalini, E. Prosperi

K-Ras, Intestinal Homeostasis and Colon Cancer

Journal: Current Clinical Pharmacology
Volume: 10 Issue: 1 Year: 2015 Page: 73-81
Author(s): Sanjay Goel,Jie Huang,Lidija Klampfer

Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3933-3943
Author(s): Sheila Piva,Monica Ganzinelli,Marina Chiara Garassino,Elisa Caiola,Gabriella Farina,Massimo Broggini,Mirko Marabese

Previous   Next

Go To   Results 1 - 1 of 1875

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy